Design and Synthesis of Potent and Multifunctional Aldose Reductase Inhibitors Based on Quinoxalinones

被引:224
作者
Qin, Xiangyu [1 ]
Hao, Xin [1 ]
Han, Hui [1 ]
Zhu, Shaojuan [1 ]
Yang, Yanchun [1 ]
Wu, Bobin [1 ]
Hussain, Saghir [1 ]
Parveen, Shagufta [1 ]
Jing, Chaojun [1 ]
Ma, Bing [1 ]
Zhu, Changjin [1 ]
机构
[1] Beijing Inst Technol, Dept Appl Chem, Beijing 100081, Peoples R China
基金
北京市自然科学基金; 中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
ACETIC-ACID DERIVATIVES; OXIDATIVE STRESS; ALDEHYDE REDUCTASE; HIGHLY POTENT; RESVERATROL; 1,1-DIOXIDE; HOLOENZYME; BIOMARKERS; FIDARESTAT; ANALOGS;
D O I
10.1021/jm501484b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Quinoxalin-2(1H)-one based design and synthesis produced several series of aldose reductase (ALR2) inhibitor candidates. In particular, phenolic structure was installed in the compounds for the combination of antioxidant activity and strengthening the ability to fight against diabetic complications. Most of the series 6 showed potent and selective effects on ALR2 inhibition with IC50 values in the range of 0.032-0.468 mu M, and 2-(3-(2,4-dihydroxyphenyl)-7-fluoro-2-oxoquinoxalin-1(2H)-yl)acetic acid (6e) was the most active. More significantly, most of the series 8 revealed not only good activity in the ALR2 inhibition but also potent antioxidant activity, and 2-(3-(3-methoxy-4-hydroxystyryl)-2-oxoquinoxalin-1(2H)-yl)acetic acid (8d) was even as strong as the well-known antioxidant Trolox at a concentration of 100 mu M, verifying the C3 p-hydroxystyryl side chain as the key structure for alleviating oxidative stress. These results therefore suggest an achievement of multifunctional ALR2 inhibitors having both potency for ALR2 inhibition and as antioxidants.
引用
收藏
页码:1254 / 1267
页数:14
相关论文
共 53 条
[1]  
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[2]   A Diverse Series of Substituted Benzenesulfonamides as Aldose Reductase Inhibitors with Antioxidant Activity: Design, Synthesis, and in Vitro Activity [J].
Alexiou, Polyxeni ;
Demopoulos, Vassilis J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (21) :7756-7766
[3]   Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century [J].
Alexiou, Polyxeni ;
Pegklidou, Kyriaki ;
Chatzopoulou, Maria ;
Nicolaou, Ioannis ;
Demopoulos, Vassilis J. .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (06) :734-752
[4]   CHARACTERIZATION OF A NOVEL ALDOSE REDUCTASE INHIBITOR, FR74366, AND ITS EFFECTS ON DIABETIC CATARACT AND NEUROPATHY IN THE RAT [J].
AO, S ;
SHINGU, Y ;
KIKUCHI, C ;
TAKANO, Y ;
NOMURA, K ;
FUJIWARA, T ;
OHKUBO, Y ;
NOTSU, Y ;
YAMAGUCHI, I .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (01) :77-87
[5]   Expanding the substitution pattern of 2(1H)-pyrazinones via Suzuki and Heck reactions [J].
Azzam, R ;
De Borggraeve, WM ;
Compernolle, F ;
Hoornaert, GJ .
TETRAHEDRON, 2005, 61 (16) :3953-3962
[6]   MECHANISM OF HUMAN ALDEHYDE REDUCTASE - CHARACTERIZATION OF THE ACTIVE-SITE POCKET [J].
BARSKI, OA ;
GABBAY, KH ;
GRIMSHAW, CE ;
BOHREN, KM .
BIOCHEMISTRY, 1995, 34 (35) :11264-11275
[7]   Resveratrol improves health and survival of mice on a high-calorie diet [J].
Baur, Joseph A. ;
Pearson, Kevin J. ;
Price, Nathan L. ;
Jamieson, Hamish A. ;
Lerin, Carles ;
Kalra, Avash ;
Prabhu, Vinayakumar V. ;
Allard, Joanne S. ;
Lopez-Lluch, Guillermo ;
Lewis, Kaitlyn ;
Pistell, Paul J. ;
Poosala, Suresh ;
Becker, Kevin G. ;
Boss, Olivier ;
Gwinn, Dana ;
Wang, Mingyi ;
Ramaswamy, Sharan ;
Fishbein, Kenneth W. ;
Spencer, Richard G. ;
Lakatta, Edward G. ;
Le Couteur, David ;
Shaw, Reuben J. ;
Navas, Placido ;
Puigserver, Pere ;
Ingram, Donald K. ;
de Cabo, Rafael ;
Sinclair, David A. .
NATURE, 2006, 444 (7117) :337-342
[8]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[9]   ANTIOXIDANT DETERMINATIONS BY THE USE OF A STABLE FREE RADICAL [J].
BLOIS, MS .
NATURE, 1958, 181 (4617) :1199-1200
[10]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820